Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)

OBJECTIVES: We previously reported inferior outcomes for locally-advanced head and neck squamous cell carcinoma (LAHNSCC) patients treated with concurrent cetuximab vs. high-dose cisplatin with intensity-modulated radiation therapy (IMRT). Prior to FDA approval of cetuximab for LAHNSCC, non-cisplati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral Oncol
Hauptverfasser: Shapiro, Lauren Q., Sherman, Eric J., Riaz, Nadeem, Setton, Jeremy, Koutcher, Lawrence, Zhang, Zhigang, Shi, Weiji, Fury, Matthew G., Wolden, Suzanne L., Pfister, David G., Morris, Luc, Lee, Nancy
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5125726/
https://ncbi.nlm.nih.gov/pubmed/25132089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2014.07.001
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge